Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

PHASE4CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

February 20, 2015

Primary Completion Date

April 16, 2018

Study Completion Date

April 16, 2018

Conditions
Influenza
Interventions
DRUG

Ergoferon

Safety and Efficacy

DRUG

Oseltamivir

Safety and Efficacy

Trial Locations (7)

117997

Pirogov Russian National Research Medical University, Moscow

194044

"Federal State Budgetary Military Educational Institution of Higher Professional Education Military-Medicine Academy named after S. M. Kirov of Ministry of Defence of Russian Federation", Saint Petersburg

194358

"St. Petersburg State Budgetary Health Care Institution City policlinic No. 117", Saint Petersburg

196143

"Limited Liability Company Scientific Research Centre Eco-safety", Saint Petersburg

214006

"Regional State Budgetary Healthcare Institution Clinical Hospital №1", Smolensk

420012

"The State Budgetary Educational Institution of Higher Professional Education Kazan State University of Medicine Ministry of Health of the Russian Federation", Kazan'

454091

"The Non-State Health Care Institution Road Hospital of the Open Joint Stock Company Russian Railways", Chelyabinsk

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT01850446 - Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza | Biotech Hunter | Biotech Hunter